Diffuse Facial Leukoderma Secondary to Localized Use of Hydroquinone

Authors

Christina Artz, Henry Ford HealthFollow
Mavra Masood, Henry Ford Health
Tasneem F. Mohammad, Henry Ford HealthFollow

Recommended Citation

Artz C, Masood M, and Mohammad TF. Diffuse Facial Leukoderma Secondary to Localized Use of Hydroquinone. Cureus 2024; 16(8):e67751.

Document Type

Article

Publication Date

8-1-2024

Publication Title

Cureus

Abstract

Disorders of hyperpigmentation are extremely common, and hydroquinone remains one of the most common treatments for hyperpigmentation. Adverse events reported with hydroquinone use include acneiform eruptions, ochronosis, and irritant dermatitis; leukoderma has been reported in rare instances. Largely, these cases report leukoderma localized to the site of application. However, we report a case of diffuse facial leukoderma with only localized use of hydroquinone. With appropriate and prompt treatment, this leukoderma can respond to vitiligo treatment algorithms.

PubMed ID

39318952

Volume

16

Issue

8

First Page

67751

Last Page

67751